Pfizer CEO defends Celebrex, will not recall drug

Celebrex: Lawyer: Monheit Law: Side Effects: Heart Attack: Pfizer

WASHINGTON, Dec 19 (Reuters) - Pfizer Chief Executive Hank McKinnell said on Sunday doctors should be made aware of the health risks in prescribing Celebrex to their patients, but the company does not plan to recall its popular arthritis drug.

Pfizer Inc. on Friday said Celebrex more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.... Full Story...

"We're leaving Celebrex on the market because it is an appropriate option for many, many patients," McKinnell said on ABC's "This Week". "Physicians do need to be fully advised of the risks and particularly this new information."

Ask Monheit Law, "Do I have a Celebrex Case?"

For more information, contact:
Michael Monheit, Esquire, Monheit Law, PC